COMMUNIQUÉS West-GlobeNewswire

Lexaria DehydraTECH Shows Promise in Nervous System Disorders -- CFN Media
05/07/2018
SEATTLE, WA, July 05, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced publication of an article [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
05/07/2018
FIT Biotech Oy Company release July 5, 2018 at 03:30 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on December 22, 2017 [...]
Hemostemix Formalizes World-Class Scientific Advisory Board
05/07/2018
CALGARY, Alberta, July 05, 2018 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“ Hemostemix ” or the “ Company ”) (TSX-V:HEM) is pleased to announce the formalization of its Scientific Advisory Board (“SAB”). Members of the SAB [...]
Top Solar System Engineer Joins International Endeavors Corp.
05/07/2018
TEMECULA, Calif., July 05, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- International Endeavors Corporation (OTC: IDVV) announces today it has secured renewable energy expert Jason Andrade as a consultant for the company [...]
IntelGenx Receives CIPO Notice of Allowance for Loxapine VersaFilm™ Patent
05/07/2018
SAINT LAURENT, Quebec, July 05, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSXV:IGX) (OTCQX:IGXT) (“IntelGenx” or the “Company”), a leading oral drug delivery company primarily focused on the development and [...]
Pivotal Trial Data for SIGA Technologies’ Oral TPOXX® Published in the New England Journal of Medicine
05/07/2018
- Results support the use of TPOXX to treat smallpox, a highly contagious and lethal virus that poses significant bioterror threat - NEW YORK, July 05, 2018 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: [...]
Zynerba Pharmaceuticals Announces Top Line Results from ZYN001 THC-Prodrug Patch Phase 1 Study
05/07/2018
DEVON, Pa., July 05, 2018 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals , Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric [...]
Theratechnologies Announces Financial Results for the Second Quarter of 2018
05/07/2018
MONTRÉAL, July 05, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX:TH) today announced its financial results for the second quarter ended May 31, 2018. Second quarter 2018 financial highlights [...]
Theratechnologies annonce ses résultats financiers du deuxième trimestre de 2018
05/07/2018
MONTRÉAL, 05 juill. 2018 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies ») (TSX:TH) a annoncé aujourd’hui ses résultats financiers pour le deuxième trimestre clos le 31 mai 2018. Faits saillants [...]
Emblem Completes Supply Agreement with Alberta Gaming, Liquor & Cannabis Commission (AGLC)
05/07/2018
PARIS, Ontario, July 05, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (TSXV:EMC.WT) (“Emblem” or the "Company") is pleased to announce that its wholly owned subsidiary, Emblem Cannabis Corporation, one of Canada’s [...]
Ogilvy CommonHealth Worldwide continues to fuel the network’s creative department with promotions and new talent
05/07/2018
PARSIPPANY, N.J., July 05, 2018 (GLOBE NEWSWIRE) -- Ogilvy CommonHealth Worldwide ( www.ogilvychww.com ), a WPP Health & Wellness company (NYSE:WPP) ( www.wpp.com ), announced three promotions and one new hire [...]
Clementia Appoints Industry Executive Shawn Tomasello to its Board of Directors
05/07/2018
Accomplished Biopharma Leader Brings Over 30 Years of Experience Leading Strategic and Commercial Efforts MONTREAL, July 05, 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (NASDAQ:CMTA), a clinical-stage [...]
Clementia nomme Shawn Tomasello, une cadre chevronnée de l’industrie, au sein de son conseil d’administration
05/07/2018
Une leader accomplie de la biopharmaceutique qui apporte 30 ans d’expérience en direction d’initiatives stratégiques et commerciales MONTRÉAL, 05 juill. 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (NASDAQ: [...]
Sernova Initiates Patient Screening and Recruitment for its US Clinical Trial for Diabetes
05/07/2018
LONDON, Ontario, July 05, 2018 (GLOBE NEWSWIRE) -- Sernova Corp. (“Sernova” or the “Company”) (TSX-V:SVA) (OTCQB:SEOVF) (FSE:PSH) announces that patient screening and recruitment has begun in its regenerative medicine [...]
Publishing of Orion Corporation's Half-Year Financial Report for January-June 2018 on 18 July 2018
05/07/2018
ORION CORPORATION PRESS RELEASE 5 JULY 2018 at 11.30 EEST Publishing of Orion Corporation's Half-Year Financial Report for January-June 2018 on 18 July 2018 Orion will publish its Half-Year Financial Report for January- [...]
Merus Announces Annual Meeting of Shareholders
05/07/2018
UTRECHT, The Netherlands, July 05, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), today announced that [...]
Solon Eiendom ASA : Major shareholding and primary insider notification
05/07/2018
(Oslo, Norway, July 4, 2018) UFI AS has today bought 251.087 shares in Solon Eiendom ASA at a price of NOK 30.00 per share. Solon Eiendom ASA Board Member Øystein A. Landvik owns 33,34 % of the shares in UFI AS. [...]
Biohit Oyj B-shares Subscribed with Stock Options I 2013
05/07/2018
Biohit Oyj Stock Exchange Release July 5, 2018 at 09:30 a.m. (EEST) A total number of 10,054 new Biohit Oyj B-shares have been subscribed for with stock options I 2013 between 7 February 2018 and 4 June 2018. These [...]
Shire plc : Rule 2.9 Announcement
05/07/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 5 July 2018 Shire [...]

Pages